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. Two isoprenoid lipids derived from intermediates in the cholesterol biosynthetic pathway are utilized by eukaryotic cells for such modification: the 15-carbon farnesyl lipid and the 20-carbon geranylgeranyl lipid [2] [3] [4] . Covalent modification of the target proteins by these lipids at a carboxyterminal cysteine residue, generally referred to as prenylation, is catalyzed by a group of enzymes known as prenyltransferases. In the human proteome, about 300 proteins, many involved in fundamental cellular functions, such as membrane trafficking and signal transduction, are modified by prenyltransferases 5 . Importantly, some oncogenic proteins, such as the activating mutant forms of H-, N-and K-RAS, require prenylation for their transforming activities 3 . Inhibition of prenylation, therefore, has been proposed as a therapeutic approach for treating the ~30% of human cancers that are driven by RAS-activating mutations [6] [7] [8] . Three prenyltransferases have been identified in mammals, farnesyltransferase (FTase), geranylgeranyltransferase type 1 (GGTase1) and geranylgeranyltransferase type 2 (GGTase2) 7, [9] [10] [11] [12] . All three prenyltransferases are heterodimeric enzyme complexes, each consisting of one α and one β subunit. FTase and GGTase1 share a common α-subunit, FNTA (also known as PTAR2), but contain distinct β-subunits, which are encoded by FNTB and PGGT1B, respectively (Fig. 1a) . The substrate specificity of FTase and GGTase1 are thought to be determined by a C-terminal CaaX sequence (C: cysteine; a: aliphatic; X: any amino acid), which constitutes the site of lipid modification. Depending on the nature of the utmost X residue, a substrate CaaX motif is recognized by either FTase for farnesylation or GGTase1 for geranylgeranylation. The third prenyltransferase, GGTase2, is formed by RabGGTA (the α-subunit, also known as PTAR3) and RabGGTB (the β-subunit) (Fig. 1a) . GGTase2 prenylates the substrate cysteine(s) in less defined C termini, including XXCC, XCCX, CCXX, CCXXX and XCXC. Unlike FTase and GGTase1, GGTase2 requires an accessory protein designated RAB escort protein that provides substrate recognition [13] [14] [15] . Although distinct groups of substrates have been identified for FTase (for example, RAS GTPases, pre-Lamin A and Lamin B), GGTase1 (for example, RHO-RAC GTPases and RAP1B) and GGTase2 (for example, RAB GTPases), several cases of cross-prenylation have been described in the literature [16] [17] [18] [19] [20] . The molecular details of crossprenylation remain unclear, underscoring the fact that we do not completely understand how these enzymes work.
F-box proteins are the substrate receptor subunits of SCF (Skp1, Cul1, F-box protein) ubiquitin ligase complexes 21, 22 . In humans, there are 69 F-box proteins, each forming a different SCF ligase and promoting the polyubiquitylation of specific substrates. Distinct from most F-box proteins, FBXL2 and its close paralog FBXL20 (the former being ubiquitous and the latter being specifically expressed in neurons [23] [24] [25] ) terminate with a prototypical CaaX motif (CVIL), which is strictly conserved across species. FBXL2 has been shown to be geranylgeranylated 26 and, on the basis of the sequence of its CaaX motif, is predicted to be a GGTase1 substrate. We have previously shown that the integrity of the CaaX motif is necessary for FBXL2 to assemble into an active SCF ubiquitin ligase complex and interact with two substrates localized at cellular membranes, p85β, a regulatory subunit of the PI3-kinase (PI3K) and IP3 (inositol 1,4,5-trisphosphate) receptor type 3 (IP3R3) [27] [28] [29] . Other independent studies have also reported membrane-localized substrates for both FBXL2 and FBXL20 (refs. 23, [30] [31] [32] ). By promoting the degradation of p85β and IP3R3 and, consequently, regulating PI3K signaling and calcium flux from the endoplasmic reticulum to the mitochondria, FBXL2 plays a critical pro-survival role [27] [28] [29] .
Here we show that FBXL2 is geranylgeranylated by a previously unknown human prenyltransferases, which we named GGTase3. A combination of cellular, biochemical and structural biology approaches has allowed us to reveal its unique mechanisms of substrate recognition.
Results
FBXL2 binds a previously unrecognized GGTase. The mammalian genome contains a single paralog of FNTA and RABGGTA encoding PTAR1 (prenyltransferase α-subunit repeat-containing protein 1), an orphan protein with unknown functions. Peptides corresponding to PTAR1 and RabGGTB were specifically identified in most FBXL2 immunopurifications that we and others analyzed using mass spectrometry 28, 33, 34 . Notably, PTAR1 and RabGGTB peptides have never been found, either in the 411 experiments reported by the contaminant repository for affinity purification-mass spectrometry data (www.crapome.org) 35 or in some 300 purifications of 26 distinct F-box proteins carried out in our laboratory, supporting the specificity of the interaction with FBXL2.
We sought to validate the binding of FBXL2 with PTAR1 and confirm its specificity by screening a panel of 15 proteins containing typical C-terminal prenylation motifs (that is, CXXX, XCXC and XXCC) for their ability to bind PTAR1 on expression in HEK-293T cells. Endogenous PTAR1 interacted specifically with FBXL2 ( Fig. 1b and Supplementary Fig. 1a ). In contrast, none of the other 14 prenyltransferase substrates (H-RAS, N-RAS, K-RAS4A, K-RAS4B, RAB23, RAP1B, RAB1a, RAB7a, RAB11, RAB23, RAB34, RAB35, M-RAS and R-RAS,) or a distinct F-box protein used as control (FBXL15) interacted with PTAR1 (Fig. 1b, Supplementary Fig. 1b and data not shown). As expected, RAS GTPases and RAP1B, but not FBXL2 or RAB GTPases, were able to co-immunoprecipitate the short and long isoforms of endogenous FNTA (Fig. 1b and Supplementary Fig. 1c ). The specificity of the interaction between PTAR1 and FBXL2 was observed even when PTAR1 was co-expressed with substrates of FTase and GGTases and when FBXL2 was expressed at lower levels than the other substrates ( Supplementary Fig. 1d,e) . Moreover, when the three human prenyltransferase α-subunits were expressed in HEK-293T cells, we found that only PTAR1, but not FNTA or RabGGTA, co-immunoprecipitated with endogenous FBXL2 (Fig. 1c) .
To confirm the binding between RabGGTB and FBXL2, we expressed either FLAG-tagged FBXL2 or GFP-tagged FBXL2 in HEK-293T cells and found that endogenous RabGGTB co-immunoprecipitated with FBXL2, but not with FLAG-tagged empty vector or GFP-tagged K-RAS4B ( Fig. 1d and Supplementary Fig. 1f ). In line with a systematic study of the human interactome 34 , FLAGtagged PTAR1 was also able to co-immunoprecipitate endogenous RabGGTB (Fig. 1d) . By co-expressing GFP-tagged FBXL2 and FLAG-tagged PTAR1 in HEK-293T cells and performing sequential immunoprecipitations, we found that FLAG-tagged PTAR1 co-immunopurified endogenous RabGGTB as well as GFP-tagged FBXL2 (Fig. 1e) . When the FLAG immunoprecipitations were subsequently eluted with an excess of FLAG peptide and re-immunoprecipitated with an anti-GFP antibody, the three proteins were again present in the second immunoprecipitation, indicating a FBXL2-PTAR1-RabGGTB ternary complex. On the basis of the above results and the fact that FLAG-tagged PTAR1 co-immunoprecipitated a greater amount of endogenous RabGGTB than FLAG-FBXL2, we hypothesized that RabGGTB might heterodimerize with PTAR1, serving as the β-subunit of a previously unrecognized prenyltransferase. To explore this possibility, we expressed the three human prenyltransferase α-subunits in HEK-293T cells and examined their binding to the three endogenous β-subunits. Similar to RabGGTA, we found that PTAR1 interacted with endogenous RabGGTB, but not FNTB and PGGT1B (Fig. 1c) . In contrast, FNTA interacted with FNTB and PGGT1B, but not RabGGTB. These data strongly support the identification of a previously unrecognized mammalian GGTase, which we named GGTase3, comprising PTAR1 and RabGGTB as α-and β-subunits, respectively (Fig. 1a) .
GGTase3 geranylgeranylates FBXL2 and targets it to cellular membranes. Previous studies have shown that FBXL2 is geranylgeranylated 26 . We found that bacterially purified FBXL2 served as a substrate of GGTase3 in vitro (Fig. 2a,b) . Notably, GGTase3 was able to in vitro geranylgeranylate FBXL2, but not K-RAS4B and FBXW7 (Fig. 2b) . We obtained identical results using two bacterial purified GGTase3 preparations that were made independently in our two laboratories using different constructs (Fig. 2a,b and Supplementary Fig. 2a ). GGTase1 was also able to prenylate FBXL2 in vitro ( Supplementary Fig. 2b ), which is expected given the presence of the typical CaaX signature motif of GGTase1 substrates in FBXL2. To investigate which of the two enzymes is responsible for FBXL2 geranylgeranylation in vivo, we incubated RPE1-HTERT1 and HeLa cells with geranylgeranyl azide and monitored the geranylgeranylation of FBXL2 using a Click-IT assay. We found that expression of PTAR1 promoted the geranylgeranylation of FBXL2, but not FBXL2(C420S), a mutant in which cysteine 420 in the CaaX motif is mutated to serine (Fig. 2c) . Moreover, we found that PTAR1 silencing using two different oligonucleotides (individually) drastically decreased the prenylation of FBXL2 in vivo (Fig. 2d) . This effect was reversed by expressing PTAR1 complementary (µM min
T-GGTase3 UT-GGTase3 geranylgeranylates purified FBXL2. Indicated amounts of purified FBXL2 were incubated with 100 ng of purified GGTase3 (either tagged (T) or untagged (UT) versions) to carry out in vitro geranylgeranylation assay using saturating concentrations of tritiated [ 3 H]GGPP as described in the Methods. Each data point represents mean ± s.d. of three biological replicates. Michaelis-Menten kinetics was used to generate an apparent K m value of 1.2 μM using Prism Graphpad software. b, In vitro geranylgeranylation assay was carried out and measured as in a using 10 µM of purified FBXL2, FBXW7 or K-RAS4B and 100 ng of purified GGTase3. Bar graphs represent mean ± s.d. from three biological replicates. Source data for panels a and b are available with the paper online. c, RPE1-HTERT cells were cotransfected with the indicated plasmids and processed for the detection of geranylgeranylated FBXL2 using a 'Click-IT' assay, as described in the Methods. The experiment was repeated three times. A representative result is shown. Uncropped blot/gel images are shown in Supplementary Data Set 1. d, HeLa cells were transfected with the indicated siRNA oligonucleotides and cDNAs. Twenty-four hours posttransfection cells were incubated with geranylgeranyl azide for 16 h, collected, lysed and azide selective ligation reaction with sDIBO-Biotin was performed for 1 h to label geranylgeranylated proteins via a copper-free 'Click-IT' reaction. After immunoprecipitation with an anti-HA antibody, immunoblots were carried out. The experiment was repeated four times. A representative result is shown. Uncropped blot/gel images are shown in Supplementary Data Set 1. e, HeLa cells were transfected first with the indicated siRNA oligonucleotides and then with the indicated GFP-tagged proteins. Live-cell confocal imaging was carried out as described in the Methods. Images show representative frames of three independent experiments. NS, non-silencing. Scale bar, 10 μm.
DNA, which was short interfering RNA (siRNA)-insensitive since the two oligonucleotides used targeted the 5′ untranslated region (UTR). This experiment demonstrated that the decrease in FBXL2 prenylation is not due to an off-target effect of the oligonucleotide to PTAR1. Silencing of FNTA or PGGT1B had no effect on FBXL2 prenylation (Fig. 2d) . However, when both PTAR1 and PGGT1B were silenced, the prenylation of FBXL2 became virtually undetectable. This result suggests that GGTase1 is able to compensate for GGTase3 in its absence. In agreement with this possibility, when PTAR1 was depleted, FBXL2 acquired the ability to bind endogenous FNTA (Supplementary Fig. 1f) .
Prenylation of proteins is required for their proper subcellular trafficking and localization. Therefore, we investigated the localization of GFP-tagged FBXL2 with and without geranylgeranylation. Using live-cell imaging confocal microscopy, we observed that GFP-FBXL2 decorated cellular membranes, including the plasma membrane and perinuclear vesicles (Fig. 2e) . In contrast, GFP-FBXL2(C420S) was observed in a homogeneous pattern in the cytoplasm (with negatively imaged organelles) and the nucleoplasm (Supplementary Fig. 2c) . Thus, the CVIL sequence in FBXL2 is required for its membrane localization. Moreover, whereas silencing FNTA or RABGGTA did not affect the subcellular localization of GFP-FBXL2, PTAR1 depletion using either a pool of four different siRNA oligonucleotides or a single one resulted in the loss of FBXL2 from the plasma membrane and its accumulation in the cytoplasm (Fig. 2e) . In contrast, PTAR1 silencing had no effect on the localization of H-RAS, RAP1B or RAB23. As expected, FNTA depletion resulted in the delocalization of both H-RAS and RAP1B, but not RAB23, and depletion of RabGGTA resulted in the delocalization of RAB23, but had no effect on the localization of H-RAS or RAP1B. Together, these results indicate that GGTase3 specifically geranylgeranylates FBXL2 and controls its cellular localization.
The relocalization of GFP-FBXL2 from the plasma membrane to the cytoplasm on knockdown of PTAR1 was unequivocal; however, GFP-FBXL2 still persisted on some vesicles (Fig. 2e) , suggesting that it has the capability to associate with membranes through a different and/or a compensatory mechanism. When both PTAR1 and FNTA were silenced, GFP-FBXL2 lost its residual vesicular localization and became homogenously distributed in the cytoplasm and the nucleus (Fig. 2e) . This is in agreement with the notion that, in the absence of PTAR1, FBXL2 becomes a 'neo-substrate' of GGTase1, as suggested by its binding to FNTA (Supplementary Fig. 1f ) and prenylation in vitro (Supplementary Fig. 2b ).
Overall structure of GGTase3-FBXL2-SKP1. Previous studies have shown that high-affinity binding of substrates to FTase and GGTase1 requires preloading of the enzymes with the farnesyl and geranylgeranyl diphosphate (FPP or GGPP) substrate, respectively [36] [37] [38] . Substrate recognition by GGTase2 also depends on an accessory protein that bridges RAB GTPases and the enzyme 13, 15 . Unexpectedly, we detected robust high-affinity (~70 nM) interaction between GGTase3 and FBXL2-SKP1, both purified from Escherichia coli, without the addition of GGPP or a GGPP analog (Fig. 3a) . To further validate their strong interaction, we coexpressed the heterodimeric GGTase3 with FBXL2-SKP1 and successfully isolated GGTase3-FBXL2-SKP1 as a tetrameric complex in equal stoichiometry (Fig. 3b) . To understand how GGTase3 assembles and recognizes FBXL2, we crystallized the GGTase3-FBXL2-SKP1 complex and determined its structure at 2.5-Å resolution ( Table 1) .
The PTAR1-RabGGTB-FBXL2-SKP1 complex adopts a torchshaped architecture with GGTase3 representing the flame emitting from the FBXL2-SKP1 handle (Fig. 3c) . Similar to the subunit of other prenyltransferase complexes 15, 39 , PTAR1 folds into an elongated crescent, mainly consisting of linearly packed α-helical hairpins. It closely wraps around the globular RabGGTB subunit, which is characterized by a zinc ion at its active site. The FBXL2 protein possesses a typical amino (N)-terminal helical F-box motif that interacts with the SCF adapter subunit SKP1 (refs. 40, 41 ). Its C-terminal domain is constructed by leucine-rich-repeats (LRRs) in a remarkably regular curved solenoid structure encompassing half a circle. GGTase3 recruits its substrate FBXL2 predominantly via a unique N-terminal extension (NTE) of PTAR1, which folds into an α/β subdomain and anchors itself onto the concave surface of the FBXL2 LRR domain. Interestingly, no electron density was found for the utmost CaaX motif-containing FBXL2 C-terminal tail, which is most likely to be disordered in the crystal (Supplementary Note 1). This observation reinforces the notion that recognition of FBXL2 by GGTase3 is mediated by interacting regions outside the C-terminal CaaX motif of the substrate. The GGTase3-FBXL2 complex buries over 2,500 Å 2 of solvent-accessible surface area, which is more extensive than that of any other prenyltransferase-substrate complexes. The high-affinity binding between GGTase3 and FBXL2 is most likely attributable to this large intermolecular interface.
GGTase3 contains a unique NTE in PTAR1. PTAR1, the α-subunit of the newly identified GGTase, harbors a series of right-handed antiparallel coiled-coils that fold into six successively packed α-helical hairpins, which are highly comparable to those of FNTA (PTAR2) and RabGGTA (PTAR3), the α-subunits of known prenyltransferases (Fig. 4a,b ) 15, 39 . Despite missing an additional α-helical hairpin at the C terminus, PTAR1 adopts the same crescent-shaped fold that envelops the RabGGTB catalytic subunit through an extensive and conserved interface found in all three previously characterized heterodimeric prenyltransferases. In complex with PTAR1, RabGGTB displays the identical α-α barrel fold as found in GGTase2, consisting of a core of six parallel helices and six peripheral helices 15 . At a funnel-shaped cavity in the center of α-α barrel, the active site of the enzyme is lined with conserved hydrophobic residues with an intrinsic zinc ion bound at the top. Overall, the architecture of GGTase3 is very similar to the known prenyltransferase complexes.
A striking structural feature that distinguishes PTAR1 from the other two prenyltransferase α-subunits is its unique NTE, which is highly conserved in animals (Supplementary Note 2) . Unlike the NTEs of the other two prenyltransferase α-subunits that are largely disordered, the PTAR1 NTE is unexpectedly well structured. The PTAR1 NTE adopts an α/β-fold starting with the α1-helix followed by a β-sheet comprising three β-stands (β1-β3) (Fig. 4a,b) . It terminates with the α2-helix, which packs orthogonally against α1 and couples NTE to the helical hairpin domain. Stabilized by a hydrophobic core, the PTAR1 NTE is highlighted by a ten amino acid loop, which is flanked by the β1-and β2-strands (hereafter referred to as β1−β2 loop). As described below, this structural loop, together with the rest of the PTAR1 NTE, plays a pivotal role in FBXL2 recruitment.
The LRR domain of FBXL2 contains an unusual pocket. The FBXL2 LRR domain contains 13 complete LRRs (LRR1-LRR13) and an additional β-strand followed by a disordered C-terminal tail with the CaaX motif (Fig. 4c) . The FBXL2 LRRs pack in tandem and produce a curved solenoid architecture resembling a semicircular arch. The concave surface of FBXL2 LRRs is formed by the interior parallel β-strands, while its convex surface is constructed by the exterior array of α-helices. In comparison to the LRR domains of other LRR-type F-box proteins 40, 42, 43 , the topology of FBXL2 LRRs displays a remarkable regularity with no atypical repeat, loop insert, abrupt kink in curvature or repeat offset. The peculiar feature of the FBXL2 LRRs, interestingly, is found at the very C-terminal end of the solenoid where the extra C-terminal β-strand forms a continuous parallel β-sheet with LRRs (Fig. 4c) . In sequence, this additional β-strand and the short loop following it are two amino acids shorter than the corresponding parts of all LRRs (Fig. 4d) . By packing against the last LRR (LRR13), it creates an unusual surface pocket, which we named the 'LRR13 pocket' , on the apical ridge of the LRR domain (Fig. 4e) . As shown in the next section, this FBXL2 pocket serves as the key docking site for GGTase3 binding.
FBXL2 and GGTase3 form a multivalent interface.
Recognition of FBXL2 by GGTase3 is exclusively mediated by the α-subunit PTAR1, which occupies the entire concave side of the F-box protein. A top view of the PTAR1-FBXL2 interface reveals that many FBXL2 LRRs from both the N-and C-terminal halves of the protein participate in PTAR1 binding, leaving only a small gap between the two proteins near the middle region of the FBXL2 solenoid (Fig. 5a) .
At the C-terminal half of the FBXL2 LRR domain, the PTAR1 NTE forms a continuous and highly complementary interface with the F-box protein. The hallmark of this interface is the interlocking engagement between the LRR13 pocket of FBXL2 and the α1-helix and the β1−β2 loop of the PTAR1 NTE (Fig. 5a,b) . The tip of the PTAR1 β1−β2 loop harbors an asparagine residue, Asn 43, which is strictly conserved among all PTAR1 orthologs (Supplementary Note 2). Acting as a claw, the PTAR1 β1−β2 loop hooks to the FBXL2 pocket with its Asn 43 residue reaching to the bottom of the pocket and forming two hydrogen bonds with FBXL2 backbone groups (Fig. 5b) . In doing so, the PTAR1 β1-β2 loop and its nearby α1-helix clamps down the short FBXL2 loop terminating the extra C-terminal β-strand, creating an interdigitated molecular interface. Similar to the tip of the PTAR1 β1−β2 loop, the short loop at the end of the FBXL2 LRR domain, which consists of three residues, Ala 398, Tyr 399 and Phe 400, also has an amino acid sequence invariant among different FBXL2 orthologs (Supplementary Note 1). Phe 400, which is the last traceable residue of FBXL2 in the crystal structure, encloses the LRR13 pocket and secures the docking of PTAR1 Asn 43 inside. Remarkably, this portion of the FBXL2-PTAR1 interface is further reinforced by a network of polar interactions taking place between the PTAR1 α1-helix and the three FBXL2 LRRs preceding LRR13 (Fig. 5b) . Together, these features of the interface strongly suggest a critical role in mediating FBXL2 binding to PTAR1.
In addition to its C-terminal LRRs, FBXL2 N-terminal LRRs are also involved in cradling PTAR1 through a relatively flat interface. The majority of the intermolecular contacts in this region are made between the apical ridge of the first five LRRs in FBXL2 and the PTAR1 loop connecting α2-and α3-helices (Fig. 5c) 
Molecular determinants of FBXL2-GGTase3 interaction.
To map the important structural elements supporting FBXL2-GGTase3 interaction, we designed and tested the binding activities of a series of PTAR1 and FBXL2 mutants by co-immunoprecipitation from HEK-293T cells. Single-or double-point mutations designed to disrupt the two Trp-Arg pairs located at the N-terminal interface only modestly compromised complex association (Fig. 5d , lanes 4 and 5 and Fig. 5e, lanes 3-8) , indicating that FBXL2-PTAR1 interactions at this region only play an accessary role in supporting FBXL2 recruitment to GGTase3. By contrast, removing the side chain of Asn 43 or deleting two amino acids at the tip of the PTAR1 β1-β2 loop severely impaired the binding of FBXL2 to PTAR1 (Fig. 5d,  lanes 2 and 3) . This effect can also be achieved, to a more complete degree, by both a triple-point mutation of the short FBXL2 loop terminating the extra C-terminal β-strand, or a truncation mutation of the F-box protein with the C-terminal β-strand entirely eliminated (Fig. 5e, lanes 9 and 10) . Together, these results definitively establish the interface at the C-terminal end of the FBXL2 LRR domain as a critical 'hotspot' for FBXL2 recognition by GGTase3.
Human FBXL2 is 423 amino acids long. The last 23 residues following Phe 400 are in a disordered conformation with no clear electron density in the crystal. On the basis of previous structural studies of FTase, GGTase1 and GGTase2 15, 37, 44, 45 , we model the C-terminal CVIL motif of FBXL2 into the catalytic pocket of GGTase3 together with a GGPP analog (Fig. 5f ). The Cα atoms of Phe 400 and the cysteine residue in the CVIL motif are separated by a distance of ~36 Å, which can be comfortably bridged by the missing 19 residues in an extended conformation. Consistent with the role of the FBXL2 LRR domain in mediating PTAR1 binding, the CVIL motif fused to GFP showed little binding to GGTase3 (data not shown). Nonetheless, mutating the cysteine residue in the FBXL2 CVIL motif weakened complex formation (Fig. 5e , lane 2), suggesting that the integrity of the C-terminal four amino acids motif contributes to the association between the F-box protein and the enzymatic complex. Interestingly, truncating the last 8 versus 21 amino acids tail of FBXL2 showed a differential impact on GGTase3 binding (Fig. 5e, lanes 11 and 12) . Therefore, it is most likely that select amino acids in the 19 residues region presumably disordered in the crystal structure also make contact to GGTase3. In agreement with this postulation, the α1-and α2-helices of the PTAR1 NTE present a hydrophobic patch in close vicinity to FBXL2 Phe 400 (Fig. 5f ), poised to interact with the following ~10 residues, which are highly conserved among FBXL2 orthologs (Supplementary Note 1) . Taken together, our mutational analysis reveals an unexpected multivalency in FBXL2-GGTase3 interaction, which spans the entire LRR domain and the C-terminal tail of the F-box protein.
Discussion
Since the 1980s, the biomedical literature has stated that mammals possess three prenyltransferases. In this study, we have identified and characterized a fourth family member, GGTase3, which consists of PTAR1, an orphan α-subunit and the β-subunit RabGGTB.
Prenyltransferases have been previously shown to share α-subunits. Our studies reveal that this important enzyme family has also evolutionarily expanded by sharing β-subunits. Notably, our structural and biochemical analyses unveil that the CaaX motif of FBXL2 contributes to, but is not sufficient for, the formation of a stable complex with GGTase3. PTAR1, instead, plays a critical role in FBXL2 recruitment through its uniquely extensive interaction with the LRR domain of the F-box protein. Therefore, in contrast to classical prenyltransferases, our results indicate that additional multivalent structural elements outside the CaaX motif contribute to the FBXL2 specificity of GGTase3. Moreover, our study suggests that GGTase1 can prenylate FBXL2, albeit with less efficiency, when GGTase3 is absent in the cell. This is yet another example that prenyltransferases are able to cross-prenylate substrates, enlightening functional compensation under specific conditions. By establishing FBXL2 as a substrate of GGTase3, we have also uncovered the first prenyltransferase that physically interacts with and modifies one of more than 600 ubiquitin ligases present in mammals to allow its localization to cell membranes, where FBXL2 has been shown to bind and ubiquitylate its substrates for subsequent proteasomal degradation.
PTAR1 has long been neglected until its identification as a gene product required for optimal fitness of cultured cells in a genomescale screen aimed at defining essential human genes 46 . FBXL2 is a pro-survival gene, whose product, in response to mitogens, inhibits apoptosis by promoting the activation of the PI3K-AKT pathway and by inhibiting mitochondrial calcium overloading [27] [28] [29] . Herein, we have shown physical and functional connections between PTAR1 and FBXL2, thereby delineating a posttranslational modification cascade critical for cell survival. Together with the detailed structural basis of enzyme assembly and substrate recognition by GGTase3, our studies elucidated the structure and function of a previously unrecognized prenyltransferase. Finally, by shedding light on the complexity of substrate recognition by this family of enzymes, our work provides additional tools for developing therapeutics targeting prenyltransferases, which, despite initial obstacles, are widely pursued for treating cancer and other human diseases.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41594-019-0249-3.
